You searched for "pharmaceuticals"
It’s not all about ARED - Time for a pragmatic approach to nutrition for eye health?
1 April 2016
| Christine Purslow (Prof)
|
EYE - Cornea
Advances in treatment for retinal diseases involving neovascularisation have undoubtedly changed the future of eye care across the UK for the better, but also created great challenges for service delivery in ophthalmology, particularly within the NHS. Some statistics are starting...
Risk of intraocular haemorrhage with new oral anticoagulants
1 December 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors conducted a study to assess the risk of intraocular haemorrhage with warfarin dabigatran, rivaroxaban, apixaban. All reported cases of intraocular haemorrhage (vitreous, choroidal, or retinal) with warfarin and new oral anticoagulants (NOACs) (including dabigatran, rivaroxaban, apixaban) from the...
NICE drugs: an update on what’s good to go
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...Registration live for 100% Ophthalmology 2025
19 September 2024
|
ophthalmology, events, conferences, industry, 100%, 100% Optical, 100% ophthalmology, London, meetings
Organisers of 100% Optical have announced that visitor registrations for 100% Ophthalmology 2025 are now live for the show set to take place at London’s ExCeL from 1–3 March. Featuring as a co-located event with 100% Optical, 100% Ophthalmology, a...
Optoversity Challenge draws 12 universities together
27 February 2025
|
charity, Vision Care for Homeless People, VCHP, fundraising, trainees, medical school, students, opportunities, competition
Out of the Box Optic’s Optoversity Challenge 2025 has brought 95 students from 12 UK universities together to take part in the exciting competition. The annual event – now in its ninth year – is a major fundraiser for Vision...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
Post-Brexit deal welcomed but leaves future relationship with EU far from settled
6 April 2021
| Rod McNeil
|
EYE - General
Rod McNeil breaks down the impact of the Brexit deal on healthcare in the UK, including medicines regulation, research funding, sharing of information and the ability to work abroad. A disorderly no-deal exit from the European Union (EU) was averted...
RCOphth Annual Congress - Day 3
25 May 2022
| Chris Henson
Follow live updates and key highlights from Day 3 of the RCOphth Annual Congress.
Introducing Danny Laycock, talent solutions specialist for the ophthalmology sector with a truly global reach
6 July 2023
|
Recruitment & Personnel
Is your company changing the future of Ophthalmics? We’re collating a list of the top companies to watch in the space for 2024.
Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology
Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology to advance ophthalmic imaging for preclinical research.Presbyopia edition of BCLA research project due to be published
A “pioneering” BCLA global consensus report will deliver evidence-based guidance to eyecare professionals on all aspects of presbyopia and its management – shaping the future of patient care for years to come.Haag-Streit UK appoints new Regional Sales Manager
25 March 2024
|
Recruitment & Personnel
Haag-Streit UK (HS-UK) is pleased to announce that Kevin Pitt has joined the company in the Surgical Division as a Regional Sales Manager for London and the South-East.
